Surescripts files motion to dismiss FTC antitrust charge

Healthcare IT News: Surescripts has moved to dismiss the Federal Trade Commission's charge from earlier this year that it holds an illegal monopoly on the e-prescribing market.

This past April, the FTC alleged that Surescripts "intentionally set out to keep e-prescription routing and eligibility customers on both sides of each market from using additional platforms (a practice known as multihoming) using anticompetitive exclusivity agreements, threats, and other exclusionary tactics."

Read article